GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaleaf Holdings Inc (TSX:CURA) » Definitions » Research & Development

Curaleaf Holdings (TSX:CURA) Research & Development : C$0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Curaleaf Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Curaleaf Holdings's Research & Development for the three months ended in Mar. 2024 was C$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was C$0 Mil.

Curaleaf Holdings Research & Development Historical Data

The historical data trend for Curaleaf Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curaleaf Holdings Research & Development Chart

Curaleaf Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Curaleaf Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Curaleaf Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curaleaf Holdings  (TSX:CURA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Curaleaf Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Curaleaf Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Curaleaf Holdings (TSX:CURA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaleaf Holdings Inc (TSX:CURA) » Definitions » Research & Development
Comparable Companies
XCNQ:GTII TSX:BHC NEOE:VRNO XCNQ:TRUL TSX:CRON TSX:TSND TSX:DHT.U TSX:WEED XCNQ:CL TSX:GUD ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
CURLF:USA
Address
420 Lexington Avenue, Suite 2035, New York, NY, USA, 10170-0052
Website
https://www.curaleaf.com
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.

Curaleaf Holdings (TSX:CURA) Headlines

No Headlines